Medtronic plc (NYSE:MDT) stock rose Wednesday after the medical device maker reported fourth-quarter revenue that exceeded Wall Street expectations, supported by strong growth in its Cardiovascular and Diabetes businesses.
Earnings Beat Expectations
Adjusted earnings came in at $1.55 per share, slightly above analysts’ estimates of $1.54 per share. Revenue increased 9.9% year over year to $9.81 billion, topping the consensus estimate of $9.64 billion. Organic revenue growth was 6.6%.
Adjusted operating profit rose 0.6% from a year earlier to $2.50 billion. Adjusted operating margin was 25.5%, down 230 basis points year over year, reflecting a 160-basis-point impact from the MiniMed Blackstone payment and an 80-basis-point impact from tariffs.
The company also increased its quarterly dividend to 72 cents per share, or $2.88 annually, marking its 49th consecutive year of dividend growth. The dividend will be paid on July 17, 2026, to shareholders of record as of June 26, 2026.
